|
|
|
OUR
STAFF
INFERTILITY
MALE
INFERTILITY
PATIENT
INFORMATION
EDUCATIONAL
ARTICLES
FERTILITY
TESTING
FERTILITY
MEDICATIONS
IVF
"ART"
THERAPIES
DONOR
EGG
IUI
FEMALE
HEALTH
ISSUES
LOCATIONS
CONTACT
US
HOME
SEARCH
OUR
SITE
|
|
Preimplantation
Genetic Diagnosis (PGD)
"Preimplantation
Genetic Diagnosis Using Embryo Biopsy and Fluorescence in situ Hybridization
(FISH), or Other Procedures Including PCR Single Gene Analysis."
PGD involves procedures that allow
for the study of specific cells, taken from embryos in the laboratory,
as a method of detecting chromosomal abnormalities, prior to the
time that such embryos are transferred to the uterus for the possible
establishment of a pregnancy. Since both analyses require examination
of the embryos in vitro (in a laboratory dish), PGD requires the
use of in
vitro fertilization (IVF).
After
genetic analysis, the patient and physician discuss the results
and what they may mean for the future development of such embryos
to assist the patient in making an informed decision as to whether
to undergo embryo transfer, and -- if so -- which embryos to select
for use in such transfer.
The
purpose of PGD is to attempt to detect chromosomal abnormalities
and potentially avoid the transfer of an embryo that has certain
abnormal chromosomes, hopefully preventing a pregnancy with an abnormal
fetus, or the possible delivery of a child with genetic defects.
Also, by selecting embryos for transfer, which, according to the
test results, appear to have the best chance for acceptable development,
it is possible that the rate of implantation may be increased and
the number of miscarriages may be reduced.
Not
all genetic defects are ascertainable using PGD, and when undergoing
PGD, there is the risk of inaccurate results. PGD offers no guarantee
that a diagnosis can be made, that pregnancy will occur, or that
a healthy child (free from genetic defects) will result. If you
elect to proceed with PGD, you must acknowledge these risks.
Any
understanding of the purposes of PGD or its methods requires some
knowledge of the genetic conditions that form the basis for the
need for PGD. Please note that The Center for Reproduction &
Women's Health Care strongly recommends that you discuss potential
genetic abnormalities with a geneticist and/or with your physician
prior to performing the genetic diagnosis on your embryos and again
after the diagnosis has been made.
Information
Concerning Genetic Abnormalities that May Affect the Health of a
Developing Embryo.
During
fertilization, the egg provides a set of chromosomes and the sperm
provides another set, resulting in two of each chromosome. However,
sometimes genetic abnormalities occur in the formation of the sperm
or eggs (or both) resulting in embryos with too many or too few
chromosomes (aneuploidy), or too many or too few parts of specific
chromosomes (translocation or inversion). For example, the embryo
should contain two copies of chromosome 21. When there is an extra
copy (three chromosome 21's), the embryo may result in an individual
with Down Syndrome (Trisomy 21).
There
are essentially three types of genetic conditions which can have
significant effects on the development of an embryo: (1) aneuploidy,
(2) translocation, or (3) inversion.
Aneuploidy
Aneuploidy
is a condition where there are either extra, or too few, chromosomes.
When the normal number of chromosomes is present, it is referred
to as euploidy. Chromosomes are "numbered" and at least
five (5) chromosomes will be tested with PGD, because such chromosomes
account for most of the chromosomal abnormalities (aneuploidy) seen
in newborns or in the tissue of miscarriages.
These
abnormalities are also found in up to approximately 50% of human
embryos and may contribute to failure of some embryos to implant
in the uterus following IVF and embryo transfer. Aneuploidy for
these chromosomes can also lead to embryo death, miscarriage, or
the live birth of an infant with substantial medical problems. In
fact, aneuploidy in a developing embryo may be associated with the
following:
-
Failure to achieve a pregnancy. Studies have demonstrated that
the majority of embryos obtained following IVF that fail to implant
in the uterus or miscarriage are aneuploid or "unbalanced."
- Loss
of a pregnancy. Chromosome abnormalities are the most common reason
for spontaneous miscarriages (loss of a pregnancy after it has
been established in the uterus).
- Offspring
born with aneuploidy or an "unbalanced state."
The medical
outcome and the quality of life achieved by children born with these
genetic abnormalities will vary depending on which chromosome(s) is
affected. If you have not already done so, you should meet with a
medical geneticist and/or a genetic counselor, which will discuss
with you the expected outcomes of children born with a genetic abnormality.
The
chance of having a miscarriage or having embryos that fail to develop
into a pregnancy increases as the age of the woman increases. There
is evidence that the relationship between these two conditions and
maternal age may be explained a higher incidence of aneuploidy in
the offspring of older women.
While
there are many chromosomal aneuploidies, the most common that occur
are with chromosomes 13, 16, 18, 21, X and Y, and include the following:
- TRISOMY
21 (one extra chromosome 21, also known as Down's syndrome) is
the most common chromosome aneuploidy found in live births. Approximately
1 in every 800 babies has it. It is associated with advanced maternal
age. Children who have Down syndrome can have varying degrees
of developmental delay. Some may be mildly affected, while others
may be more severely delayed. Some children with Down syndrome
have other associated medical problems, like heart defects or
leukemia that may require medical management.
- TRISOMY
13 (one extra chromosome 13) In the general population, 1 in every
5,000 babies born has trisomy 13. Trisomy 13 is associated with
advanced maternal age. These babies have multiple system abnormalities,
including abnormalities of the heart, brain and cleft lip/plate.
Babies with trisomy 13 have limited life span. Most of them die
within the first few months of life, and those that do survive
are severely delayed in growth and development.
- TRISOMY
18 (one extra chromosome 18) Approximately 1 in every 3,000 live
births results in trisomy 18. It is associated with advanced maternal
age. Most babies with trisomy 18 have multiple abnormalities including
heart, brain, mental retardation and delayed growth. Most of the
babies do not survive more than a few months.
-
XXX (one extra X chromosome resulting in three X chromosomes)
Incidence of XXX is approximately 1 in 1,100. XXX is also associated
with advanced maternal age. These are normal appearing, fertile
females who may present with learning disabilities.
-
XXY (one extra X chromosome in a male) this occurs in about 1
in 1,100 births. These males are normal in appearance and are
often taller than other male siblings. There are some studies
suggesting that these males may have behavioral problems but generally
have a normal IQ.
- XO
(missing one X chromosome; also referred to as Turner's syndrome)
this occurs in about 1 in every 5,000 live births. These females
have normal IQ, but generally are shorter than expected and may
have other physical abnormalities, such as congenital heart defects.
Growth can be enhanced with hormone therapy. These women are usually
infertile; however, they do have a uterus and can conceive and
carry to term with the help of IVF using donor eggs.
- Monosomes
for Chromosomes 13, 15, 16, 17, 18, 21, 22, X and Y (Only one
of a particular chromosome is present instead of the typical two
chromosomes) Monosomy 21 (one chromosome 21) is only seen in tissue
from miscarriages. The other monosomies have never been seen in
miscarriages or in children. It is therefore, believed that embryos
that are missing one of these chromosomes are not able to implant
into the uterus.
Translocation
or Inversion ("Unbalanced State")
An
"unbalanced state" may result from either translocation
or inversion:
a.
Translocation is the presence of a translocation chromosome (chromosomal
rearrangement) that can cause the embryo to have too many copies
or parts of one chromosome and too few copies or parts of the other.
This results in too many or too few normal genes on a chromosome.
This is called an "unbalanced state", meaning that the
embryo does not have the proper amount of genetic material.
Where
one of the patients is known to carry a translocation chromosome
involving specific chromosome(s), those chromosomes will be tested
utilizing PGD.
An "unbalanced state" or translocation in an embryo may
lead to embryo death, miscarriage, or the live birth of an infant
with substantial medical problems. Listed below are very brief descriptions
of some of the possible abnormalities that are found when there
is the transfer of a balanced or unbalanced translocation or inversion
chromosome to one's offspring.
b.
Inversions B occur when a single chromosome breaks in two places
and the material in-between is reconstituted upside down. The presence
of this inversion chromosome in eggs or sperm can result in an embryo
with too many or too few copies of genes located on particular chromosomes.
This
can also be considered an "unbalanced state." Where one
of the patients is known to carry an inversion of a particular chromosome(s),
those chromosomes will be tested utilizing PGD. A pregnancy involving
an embryo with too many or too few copies of genes (from this inverted
chromosome) may result in the failure of the embryo to grow, miscarriage,
or the birth of a severely-affected child with substantial medical
problems.
Translocation
or Inversion ("Balanced State")
There
may also be "balanced" translocations or inversions, which
means that there is a translocation (rearrangement) or inversion
(material upside down) but there are the right number of copies
of genes. When one partner carries a balanced translocation or inversion
chromosome, this intact chromosome can be transferred to their offspring.
While
the child would be "normal", that child may transmit this
abnormal chromosome to his/her offspring. The FISH technique of
analysis (described later) cannot differentiate between the presence
of a balanced translocation chromosome and a normal chromosome.
When
one partner carries a balanced translocation or inversion chromosome,
this chromosome can separate and transfer too few or too many copies
of a chromosome to the embryos, which can lead to abnormal genetic
conditions. There may be a resultant failure to conceive, miscarriage,
fetal death or the birth of a severely affected child with a genetic
disorder. Please read
our PGD Patient Handout.
|
|